ETHYL 2-((3S)-7-((4-CYCLOPENTYL-3-(TRIFLUOROMETHYL)PHENYL)METHOXY)-1,2,3,4-TETRAHYDROCYCLOPENTA(B)INDOL-3-YL)ACETATE
UNII 3F3PH4SV2K

Substance Identification & Data

This profile provides standardized clinical and technical data for Ethyl 2-((3s)-7-((4-cyclopentyl-3-(trifluoromethyl)phenyl)methoxy)-1,2,3,4-tetrahydrocyclopenta(b)indol-3-yl)acetate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3F3PH4SV2K.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2056251-50-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3F3PH4SV2K

CAS Registry Number

2056251-50-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ETHYL 2-((3S)-7-((4-CYCLOPENTYL-3-(TRIFLUOROMETHYL)PHENYL)METHOXY)-1,2,3,4-TETRAHYDROCYCLOPENTA(B)INDOL-3-YL)ACETATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C28H30F3NO3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

MOIBBQFSBRXTDL-IBGZPJMESA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

173991689

Unique identification number in the NCBI database of chemical substances.

Substance Type

Ethyl 2-[(3S)-7-[[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy]-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetate

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(C(OCC)=O)[C@H]1c2c(c3c([nH]2)ccc(OCc4cc(C(F)(F)F)c(cc4)C5CCCC5)c3)CC1

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ethyl 2-((3s)-7-((4-cyclopentyl-3-(trifluoromethyl)phenyl)methoxy)-1,2,3,4-tetrahydrocyclopenta(b)indol-3-yl)acetate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.